GLP-1 drugs have risen to become the fastest-growing segment of drug expenditure, accounting for 10.5% of pharmacy costs in 2024. Employers are seeing average annual costs between $8,000 and $10,000 per user for these medications. GoodRx CEO Wendy Barnes announced a price of $499 a month for some GLP-1 drugs. This pricing strategy raises questions about the future of drug spending outside traditional insurance models. Experts emphasize the need for greater consumer choice in healthcare, mirroring shopping experiences in other economic sectors.
"I would challenge the notion that all drug spend needs to flow through an insured model. We're trying to get competitive pricing in the hands of every American."
"In every other part of the economy, I get to buy the product I want at the price I want to pay, and I have an opportunity to shop and see what's available."
Collection
[
|
...
]